Coating of human decay accelerating factor (hDAF) onto medical devices to improve biocompatibility (Q42061168)

15 October 2017

title

Coating of human decay accelerating factor (hDAF) onto medical devices to improve biocompatibility (English)

1 reference

15 October 2017

1 reference

N. J. Watkins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9476122

8 December 2024

P. Braidley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9476122

8 December 2024

C. J. Bray

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9476122

8 December 2024

C. M. Savill

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9476122

8 December 2024

D. J. White

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9476122

8 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9476122

8 December 2024

publication date

1 December 1997

1 reference

15 October 2017

December 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9476122

full work available at URL

8 December 2024

https://api.elsevier.com/content/article/PII:S0162310997000684?httpAccept=text/xml

1 reference

10.1016/S0162-3109(97)00068-4

DOI

https://api.crossref.org/works/10.1016/S0162-3109(97)00068-4

https://api.elsevier.com/content/article/PII:S0162310997000684?httpAccept=text/plain

8 December 2024

1 reference

10.1016/S0162-3109(97)00068-4

DOI

https://api.crossref.org/works/10.1016/S0162-3109(97)00068-4

8 December 2024

1 reference

15 October 2017

1 reference

15 October 2017

issue

1-2

1 reference

15 October 2017

page(s)

111-118

1 reference

Structure, organization, and regulation of the complement genes

15 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900068-4

7 January 2021

Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900068-4

7 January 2021

Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900068-4

7 January 2021

Complement activation produced by biomaterials

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900068-4

7 January 2021

Chemical Cross-Linking in Biology

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900068-4

7 January 2021

Expression of the glycosylphosphatidylinositol-linked complement-inhibiting protein CD59 antigen in insect cells using a baculovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900068-4

7 January 2021

Isolation of decay accelerating factor (DAF) by a two-step procedure and determination of its N-terminal sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900068-4

7 January 2021

Surface-bound heparin--panacea or peril?

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900068-4

7 January 2021

Effects of inhibition of complement activation using recombinant soluble complement receptor 1 on neutrophil CD11b/CD18 and L-selectin expression and release of interleukin-8 and elastase in simulated cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900068-4

7 January 2021

Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900068-4

7 January 2021

Inhibition of complement by a substance isolated from human erythrocytes. I. Extraction from human erythrocyte stromata.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900068-4

7 January 2021

Activation of the complement system at the interface between blood and artificial surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900068-4

7 January 2021

Overexpression, purification, and characterization of third component of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900068-4

7 January 2021

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900068-4

7 January 2021

Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900068-4

7 January 2021

Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900068-4

7 January 2021

A novel procedure for labeling immunoglobulins by conjugation to oligosaccharide moieties

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900068-4

7 January 2021

Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900068-4

7 January 2021

Inhibition of Terminal Complement Complex Formation and Cell Lysis by Monoclonal Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900068-4

7 January 2021

10.1016/S0162-3109(97)00068-4

Identifiers

DOI

1 reference

15 October 2017

1 reference